Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.

ABSTRACT:

Background

Stenotrophomonas maltophilia is one of the most common emerging multi-drug resistant organisms found in the lungs of people with cystic fibrosis and its prevalence is increasing. Chronic infection with Stenotrophomonas maltophilia has recently been shown to be an independent predictor of pulmonary exacerbation requiring hospitalization and antibiotics. However, the role of antibiotic treatment of Stenotrophomonas maltophilia infection in people with cystic fibrosis is still unclear. This is an update of a previously published review.

Objectives

The objective of our review is to assess the effectiveness of antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. The primary objective is to assess this in relation to lung function and pu

SUBMITTER: Amin R 

PROVIDER: S-EPMC7080526 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature